Skip to Main Content

Paper Details

Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations.
Cancer Discov
4
2024
Author NameAffiliation
Ignaty LeshchinerBroad Institute of Massachusetts Institute of Technology and Harvard
Gerburg M WulfHarvard Medical School
Steven J IsakoffMassachusetts General Hospital
Gad GetzBroad Institute of the Massachusetts Institute of Technology and Harvard
Gad GetzBroad Institute of the Massachusetts Institute of Technology and Harvard
  • 1 - 5

Datasets